DROXIA (HYDROXYUREA) — FDA Approval NDA016295 (WAYLIS THERAP)
DROXIA (HYDROXYUREA) — FDA Approval NDA016295 (WAYLIS THERAP) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: DROXIA; Active ingredients: HYDROXYUREA; Application number: NDA016295.
| Brand name | DROXIA |
|---|---|
| Active ingredients | HYDROXYUREA |
| Application number | NDA016295 |
| Sponsor | WAYLIS THERAP |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 4 |
| First approval date | 19671207 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →